We are live on ! Find out more
TC

Tejara Capital Portfolio holdings

AUM $303M
1-Year Est. Return 5.43%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+5.43%
3 Year Est. Return
+13.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$203M
AUM Growth
+$7.77M
Cap. Flow
+$5.8M
Cap. Flow %
2.85%
Top 10 Hldgs %
52.75%
Holding
96
New
15
Increased
24
Reduced
31
Closed
26

Top Buys

Rank Stock Value
1
GLNG icon
Golar LNG
GLNG
+$5.36M
2
BP icon
BP
BP
+$5.13M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.29M
4
NOV icon
NOV
NOV
+$3.72M
5
NE icon
Noble Corp
NE
+$3.7M

Top Sells

Rank Stock Value
1
COOP
Mr. Cooper
COOP
+$5.12M
2
HTZ icon
Hertz
HTZ
+$4.19M
3
BABA icon
Alibaba
BABA
+$4.09M
4
FTI icon
TechnipFMC
FTI
+$3.93M
5
ALLY icon
Ally Financial
ALLY
+$3.06M

Sector Composition

Rank Sector Weight
1 Energy 67.16%
2 Healthcare 17.77%
3 Industrials 4.1%
4 Financials 3.39%
5 Materials 2.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNW icon
51
ReNew
RNW
$2.2B
$580K 0.29%
+105,900
New +$580K
PTVE
52
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$575K 0.28%
75,931
-4,069
-5% -$31.1K
HP icon
53
Helmerich & Payne
HP
$3.36B
$518K 0.25%
+14,600
New +$498K
PUMP icon
54
ProPetro Holding
PUMP
$1.32B
$513K 0.25%
+62,300
New +$457K
DNOW icon
55
DNOW Inc
DNOW
$2.59B
$502K 0.25%
+48,503
New +$487K
ATAI icon
56
AtaiBeckley Inc
ATAI
$2.65B
$499K 0.25%
290,215
+19,215
+7% +$35.4K
KNSA icon
57
Kiniksa Pharmaceuticals
KNSA
$4.89B
$478K 0.24%
33,931
-14,569
-30% -$195K
CMRX
58
DELISTED
Chimerix, Inc.
CMRX
$451K 0.22%
372,640
-19,719
-5% -$25K
CRDL
59
Cardiol Therapeutics
CRDL
$134M
$442K 0.22%
497,061
+56,435
+13% +$37.3K
TRVI icon
60
Trevi Therapeutics
TRVI
$2.57B
$431K 0.21%
180,227
-9,991
-5% -$25.2K
ABUS icon
61
Arbutus Biopharma
ABUS
$871M
$414K 0.2%
180,077
-19,923
-10% -$51.9K
STRO icon
62
Sutro Biopharma
STRO
$398M
$412K 0.2%
8,868
+4,420
+99% +$220K
VAPO
63
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$383K 0.19%
107,467
-760
-0.7% -$3.49K
OVID icon
64
Ovid Therapeutics
OVID
$439M
$369K 0.18%
112,591
-6,200
-5% -$21.1K
VINC
65
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$303K 0.15%
11,667
-2,877
-20% -$82.3K
METCB icon
66
Ramaco Resources Class B
METCB
$462M
$297K 0.15%
+30,173
New +$291K
CELL
67
DELISTED
PhenomeX Inc. Common Stock
CELL
$135K 0.07%
276,101
-16,278
-6% -$13.3K
FREE
68
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$124K 0.06%
30,805
-57,989
-65% -$162K
IVZ icon
69
PUT
Invesco
IVZ
$13.3B
$123K 0.06%
+3,000
New +$48.3K
DTIL icon
70
Precision BioSciences
DTIL
$187M
$104K 0.05%
6,620
-370
-5% -$8.46K
ADEA icon
71
Adeia
ADEA
$2.88B
– –
-69,100
Closed -$612K
ALEC icon
72
Alector
ALEC
$168M
– –
-23,697
Closed -$147K
ALLY icon
73
Ally Financial
ALLY
$13.3B
– –
-120,000
Closed -$3.06M
ANIP icon
74
ANI Pharmaceuticals
ANIP
$1.78B
– –
-7,600
Closed -$302K
AP icon
75
Ampco-Pittsburgh
AP
$177M
– –
-45,293
Closed -$111K
1 2
3
4

Similar funds

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
ECAM
East Coast Asset Management Essex, Massachusetts $303M AUM 35.55% 1-Year Est. Return
BPH
Boundless Plain Holdings Hong Kong $304M AUM
BCC
Bain Capital Credit Boston, Massachusetts $303M AUM 15.47% 1-Year Est. Return
BKA
Brick & Kyle Associates Newtown, Pennsylvania $303M AUM 26.39% 1-Year Est. Return
SF
Slagle Financial Edwardsville, Illinois $303M AUM 23.03% 1-Year Est. Return
AFO
Arrowroot Family Office Marina Del Rey, California $302M AUM 14.21% 1-Year Est. Return
OWM
OneAscent Wealth Management Birmingham, Alabama $302M AUM 15.12% 1-Year Est. Return

Tejara Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Tejara Capital held 96 positions worth $203M, up 4% from $195M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Tejara Capital's Q2 2023 filing shows 15 new, 24 increased, 31 reduced and 26 closed positions. Its largest new stake was BP: 138,745 shares worth $3.69M. The largest sale was Mr. Cooper, an estimated $5.12M.

By sector, the portfolio is most concentrated in Energy at 67% of assets, up from 58% a quarter earlier, followed by Healthcare and Industrials.

  • Tejara Capital's largest Q2 2023 buy was BP: 138,745 shares worth $3.69M.
  • Tejara Capital added most to Golar LNG in Q2 2023, an estimated $5.36M increase.
  • Tejara Capital's biggest Q2 2023 reduction was Core Natural Resources Inc, cutting an estimated $2.25M.
  • Tejara Capital fully exited Mr. Cooper in Q2 2023, selling an estimated $5.12M.
  • Tejara Capital's ten largest holdings make up 53% of its $203M portfolio in Q2 2023.
  • Tejara Capital opened 15 new positions and closed 26 in Q2 2023.
  • Tejara Capital's portfolio value rose 4% quarter-over-quarter to $203M.

Based on Tejara Capital's 13F filing for Q2 2023, filed 11 Aug 2023.